Okawa, Japan

Masanobu Nakao

This inventor holds 5 USPTO granted patents. Top assignees: Green Peptide Co., Ltd., Kyogo Itoh. Active years: 2005-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanobu Nakao. Retrieved from https://idiyas.com/inventor/masanobu-nakao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2005-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Masanobu Nakao

Introduction

Masanobu Nakao is a prominent inventor based in Okawa, Japan. He has made significant contributions to the field of tumor research, holding a total of five patents. His work focuses on novel tumor antigen proteins and their applications in diagnostics and therapeutics.

Latest Patents

Nakao's latest patents include the development of tumor antigen protein SART-3 and tumor antigen peptides derived from this protein. These innovations provide a novel tumor antigen protein and gene, along with medicaments, prophylactics, or diagnostics for tumors using such tumor substances in vitro or in vivo. His research aims to enhance the understanding and treatment of tumors, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Nakao has worked with various companies, including Green Peptide Co., Ltd. and Kyogo Itoh. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Nakao has collaborated with Kyogo Itoh, further enhancing his research capabilities and expanding the impact of his innovations.

Conclusion

Masanobu Nakao's contributions to tumor research through his patents and collaborations highlight his dedication to improving medical diagnostics and treatments. His work continues to influence the field and offers hope for advancements in cancer therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…